Life Sciences

Meest recente

• You're currently reading page 1
• Page 2
• Page 3
• Page 4
• Page 5
• Page 6
• Page 7
• …
• Page 71
• Page 72
• Volgende: Page >

• Advocate General delivers opinion in the first of three CJEU referrals concerning Article 3(a) of the SPC Regulation

  Artikel

  Ingediend: 25 April 2018

  The Advocate General (Wathelet) has handed down his opinion in Teva v Gilead (Case C-121/17) on the interpretation of Article 3(a) of the SPC Regulation.

• Less than 12 months to Brexit: Are you ready?

  Webinar

  Ingediend: 25 April 2018

  Find training materials and on demand videos from our "Less than 12 months to Brexit: Are you ready?" event.

• Podcast 632: How should businesses prepare for GDPR? Privacy impact assessments

  Video Podcast

  Ingediend: 23 April 2018

  Privacy impact assessments will be required where a company engages in high risk processing. This podcast looks at what to cover in and how to run privacy impact assessments.

• Busting the Blockchain myth in healthcare

  Conferentie

  Datum: 23 May 2018

  One HealthTech and Simmons & Simmons present an evening of fresh, thought-provoking discussion on blockchain in healthcare.

• Orphan drug exclusivity: case law update

  Artikel

  Ingediend: 19 April 2018

  In this article, we recap on the earlier Teva v EMA decision and summarise the recent outcome in Shire v EMA. We have also included relevant parts of the Regulation 141/2000 on Orphan Medicinal Products in the Annex hereto.

• High Court rules on the requirements of "exclusivity" in patent licensing arrangements in two recent decisions

  Artikel

  Ingediend: 16 April 2018

  The court’s recent decisions in Illumina, Inc & Ors v Premaitha Health Plc & Ors [2017] EWHC 2930 (Pat) and Oxford Nanopore Technologies & Anor v Pacific Biosciences of California, Inc & Anor [2017] EWHC 3190 (Pat) serve as a helpful reminder as to how the court will assess whether a licence is truly “exclusive” for the purposes of section 130(1) of the Patent Act 1977.

• Podcast 631: How should businesses prepare for GDPR? Development of a record of processing activities

  Video Podcast

  Ingediend: 16 April 2018

  One of the new GDPR requirements is creating and maintaining a record of processing activities. This podcast deals with how to create and maintain that record.

• Sunshine Act: Last-minute checklist ahead of the deadline

  Artikel

  Ingediend: 13 April 2018

  The final date to upload transparency reports on www.betransparent.be is Thursday 31 May 2018. Ahead of this final date, we prepared a checklist with practical action points to consider ahead of the deadline.

• Recommandations sur les procédures de retrait et de rappel des produits alimentaires présentant un risque sanitaire

  Artikel

  Ingediend: 12 April 2018

  Conclusions des travaux des Commissions des affaires économiques et des affaires sociales du 28 mars et 5 avril 2018.

• LLP Agreements and Shareholders' Agreements: "same same but different"?

  Artikel

  Ingediend: 12 April 2018

  The commercial purpose of a company and a limited liability partnership (LLP) is often, in essence, the same: to serve as a vehicle through which a business is operated. So, temptation naturally abounds to apply the same commercial concepts to both LLP Agreements and Shareholders’ Agreements. Is this approach dangerous?

• You're currently reading page 1
• Page 2
• Page 3
• Page 4
• Page 5
• Page 6
• Page 7
• …
• Page 71
• Page 72
• Volgende: Page >